ArticleMedicine international
Percutaneous ablation of intrathyroidal parathyroid adenoma: A case report and brief review of the literature.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hyperparathyroidism (HPT), predominantly caused by parathyroid adenomas (PAs), leads to elevated calcium levels and a range of complications, including renal, skeletal and cardiovascular issues. While parathyroidectomy is the standard treatment for resolving hypercalcemia, the present study describes a case of intrathyroidal PA treated with microwave ablation (MWA). A 29-year-old woman with recurrent HPT presented with elevated parathyroid hormone (183 pg/ml) and serum calcium (11.06 mg/dl) levels following a previous right upper and lower parathyroidectomy. Imaging revealed a well-defined hypoechoic nodule within the right thyroid lobe, confirmed as an intrathyroidal PA following sestamibi scanning. The patient underwent MWA, achieving the rapid normalization of parathyroid hormone and calcium levels. Although PA is a common cause of primary HPT, a thorough review of the literature found no instances of intrathyroidal PA treated with MWA. On the whole, the present case report demonstrates that MWA may be a safe and effective alternative for the treatment of intrathyroidal PAs, particularly when traditional surgery is not a viable option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.